Publication: Comparative Effectiveness of Natalizumab, Fingolimod, and First-Line Therapies for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
WoS Q
Q1
Scopus Q
Q1
Source
Multiple Sclerosis Journal
Volume
26
Issue
Start Page
526
End Page
527